menu search

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position expected to fund operations into second quarter of 2025 Two Phase 1 clinical trials of lead program, TIDAL-01, in several solid tumor Indications ongoing SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics […] The post Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update appeared first on... Read More
Posted: Sep 1 2023, 21:57
Author Name: forextv
Views: 111692

Search within

Pages Search Results: